Arena Pharmaceuticals, Inc.
NASDAQ: ARNA
$99.99
+$0.00 (+0.0%)
Closing price March 15, 2022
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates for the rest of March.
Published:
Last Updated:
Credit Suisse sees tax reform sparking a wave of mergers in the emerging pharmaceuticals space, which could produce sector outperformance. The firm is cautiously optimistic on this front.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Bank of America, Honeywell, IBM, Lululemon Athletica, Oracle, United Technologies and Wells Fargo.
Published:
Last Updated:
Ahead of the California legalization efforts, a U.S.-listed marijuana-focused exchange traded fund has quietly begun trading.
Published:
Last Updated:
Shares of Arena Pharmaceuticals saw an incredible gain early Tuesday after the company reported positive results from its mid-stage trial in patients with pulmonary arterial hypertension.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess and Western Digital.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls include Alphabet, Enterprise Products, GrubHub, Mattel, Ryanair and Splunk.
Published:
Last Updated:
The the man in charge of one of the nation's biggest railroads was among insiders making notable purchases of shares this past week.
Published:
Last Updated:
Valeant, Arena, Teva, and Frontier Communications all posted new 52-week lows on Tuesday.
Published:
Last Updated:
Arena Pharmaceuticals saw its shares drop sharply on Tuesday after the company announced a secondary offering of 60 million shares of its common stock.
Published:
Last Updated:
The broad markets are inching forward on Wednesday after hitting new highs in what has been known as the Trump rally. Although the SPDR S&P Biotech ETF (NYSEMKT: XBI) is up about 1% on the day,...
Published:
Last Updated:
The impact of cannabis products is expected to grow to an estimated $44 billion by 2020. Which companies will be earning those billions?
Published:
Last Updated:
These biotech companies stood out from the rest with incredible gains or losses over the course of the past week.
Published:
Last Updated:
Arena Pharmaceuticals saw its shares jump in Monday’s session on news of an U.S. Food and Drug Administration (FDA) approval.
Published:
Last Updated:
A new research note from the quantitative strategies team at Jefferies highlights the top buys and sells for the Russell 1000 and Russell 2000. These five companies will see the most shares bought on...
Published: